![Rhonda Farnum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 31/07/2026
Ms. Rhonda F.
Farnum is a Chief Business Officer & SVP-Medical Affairs at Theravance Biopharma, Inc. Ms. Farnum was previously employed as a Head-Hematology Business Unit by Onyx Pharmaceuticals, Inc. She received her undergraduate degree from the University of Georgia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
THERAVANCE BIOPHARMA INC 0,44 % | 20/08/2026 | 226.790 ( 0,44 % ) | 4 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Director Técnico/Científico/I+D | - |
| Empresas | Cargo | Fin |
|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01/08/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
